Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid

被引:213
作者
Lim, SJ [1 ]
Kim, CK [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Natl Res Lab Drug & Gene Del,Kwanak Gu, Seoul 151742, South Korea
关键词
all-trans retinoic acid; solid lipid nanoparticle; stability; freeze-drying;
D O I
10.1016/S0378-5173(02)00269-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid lipid nanoparticles (SLNs) have gained attention as a colloidal drug carrier, particularly for drugs with limited solubility. The poor aqueous solubility of all-trans retinoic acid (ATRA) has been a limiting factor in its clinical use. This study was undertaken to overcome the solubility limitation of ATRA by loading in SLNs. The physicochemical characteristics of ATRA-loaded SLNs were investigated by particle size analysis, zeta potential measurement, thermal analysis and HPLC determination of ATRA content. The mean particle size of ATRA-loaded SLNs could be reduced (1) by mixing EggPC and Tween 80 as a surfactant and (2) by increasing the total surfactant amount. The smallest mean particle size of SLNs was obtained with 50 mg/g surfactant mixture composed of 54:46% (w/w) EggPC:Tween 80 (154.9 nm). The zeta potential of SLNs could be increased by mixing EggPC, Tween 80 and DSPE-PEG in the surfactant mixture. The zeta potential of SLNs prepared with 50 mg/g surfactant mixture composed of 48:6:46% (w/w) of EggPC:DSPE-PEG:Tween 80 was -38.18 mV. ATRA could be loaded at 2.4% (percentage of lipid matrix) on these SLNs without impairing their physical stability. After freeze-drying, the mean particle size and polydispersity index of ATRA-loaded SLNs were only slightly increased (181.8 vs. 265.2 nm, 0.173 vs. 0.200). Furthermore, no significant change was observed in the SLN-loaded concentration of ATRA and the zeta potential of SLNs after freeze-drying. Taken together, SLN formulation of ATRA with similar characteristics to those of parenteral emulsions could be obtained even after freeze-drying. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 30 条
[1]   MOLECULAR MECHANISM OF THE LIPID VESICLE LONGEVITY INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1146 (02) :157-168
[2]   Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles [J].
Cavalli, R ;
Caputo, O ;
Carlotti, ME ;
Trotta, M ;
Scarnecchia, C ;
Gasco, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 148 (01) :47-54
[3]   In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel [J].
Chen, DB ;
Yang, TZ ;
Lu, WL ;
Zhang, Q .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (11) :1444-1447
[4]   Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase [J].
Freitas, C ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) :125-132
[5]  
Gohla SH, 2001, PHARMAZIE, V56, P61
[6]   Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride [J].
Heiati, H ;
Phillips, NC ;
Tawashi, R .
PHARMACEUTICAL RESEARCH, 1996, 13 (09) :1406-1410
[7]   Solid lipid nanoparticles as drug carriers .1. Incorporation and retention of the lipophilic prodrug 3'-azido-3'-deoxythymidine palmitate [J].
Heiati, H ;
Tawashi, R ;
Shivers, RR ;
Phillips, NC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 146 (01) :123-131
[8]  
Jenning V, 2001, J MICROENCAPSUL, V18, P149
[9]   Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization [J].
Joshi, M ;
Misra, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 223 (1-2) :15-27